Comment on 'Four-year data from use of the nut and soya allergy testing protocol before treatment with isotretinoin and alitretinoin'.

McCarthy, S; Murphy, M; Turner, P J; Hourihane, O B

McCarthy, S; Murphy, M; Turner, P J; Hourihane, O B.

Afiliação

McCarthy S; Department of Paediatric Dermatology, Children's Health Ireland, Crumlin, Dublin, Ireland.
Murphy M; Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
Turner PJ; National Heart and Lung Institute, Imperial College London, London, UK.
Hourihane OB; Paediatrics and Child Health and RCSI and Children's Health Ireland, Temple Street, Dublin, Ireland.

Clin Exp Dermatol ; 45(8): 1071, 2020 12.

Article em En | MEDLINE | ID: mdl-32686162

Assuntos

Isotretinoína; Hipersensibilidade a Noz; Alitretinoína; Humanos; Isotretinoína/efeitos adversos; Nozes; Glycine max

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isotretinoína / Hipersensibilidade a Noz Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google